Cell-mediated cytotoxic activity of regional lymph node cells from patients with gastric carcinoma
- 18 Downloads
The cell-mediated cytotoxic activities of cells from the perigastric lymph nodes (LNC) were assayed in patients with gastric carcinoma. These activities were compared with those of the peripheral blood mononuclear cells (PBM), and also with the LNC of patients with benign lesions. The capacity of LNC to be converted to cytotoxic cells in mixed cell culture was significantly impaired in the cancer patients as compared to that of either the PBM from the same patients, or the LNC from patients with benign lesions. The natural killer cell (NK) activity of LNC was significantly lower than that of the PBM in both groups of patients. The cytotoxic activity induced by phytohemagglutinin activation (PAK) in the LNC from patients with carcinoma, as well as from those with benign lesions was also significantly decreased, when compared to that of the PBM, although the ability of LNC to produce interleukin 2 (IL 2) was significantly increased. The ability of these cells to generate cytotoxicity after activation with IL 2 (LAK) was therefore examined, and a decreased capacity in LNC was observed. These results indicated that the ability of T cells in LNC to develop into cytotoxic cells in patients with gastric carcinoma was impaired, and that the nonspecific cytotoxicity, including NK or PAK, as well as LAK activity, was essentially low in the perigastric lymph nodes.
Key Wordscell-mediated cytotoxicity regional lymph nodes gastric carcinoma
Unable to display preview. Download preview PDF.
- 1.Niitsuma M, Golub SH, Edelstein R, Holmes EC. Lymphoid cells infiltrating human pulmonary tumors: Effect of intralesional BCG injection. JNCI 1981; 76: 996–1003.Google Scholar
- 2.Vose BM, Vanky F, Argov S, Klein E. Natural cytotoxicity in man: Activity of lymph node and tumorinfiltrating lymphocytes. Eur J Immunol 1977; 7: 753–757.Google Scholar
- 5.Mazumder A, Grimm EA, Zhang HZ, Rosenberg SA. Lysis of fresh human solid tumors by autologous lymphocytes activatedin vitro with lectins. Cancer Res 1983; 42: 913–918.Google Scholar
- 8.Grimm EA, Ramsey KM, Mazumder A, Wilson DJ, Djeu JY, Rosenberg SA. Lymphokine-activated killer cell phenomenon. II. Precursor phenotype is serologically distinct from peripheral T lymphocytes, memory cytotoxic thymus-derived lymphocytes, and natural killer cells. J Exp Med 1983; 157: 884–897.PubMedCrossRefGoogle Scholar
- 9.Grimm EA, Robb RJ, Ross JA, Neckers LM, Lachman LB, Wilson DJ, Rosenberg SA. Lymphokine-activated killer cell phenomenon. III. Evidence that IL 2 is sufficient for direct activation of peripheral blood lymphocytes into lymphokine-activated killer cells. J Exp Med 1983; 158: 1356–1367.PubMedCrossRefGoogle Scholar
- 13.Spina CA, Dorey F, Vescera C, Brosman S, Fahey JL. Depression of the generation of cell-mediated cytotoxicity by macrophage-like suppressor cells in bladder carcinoma patients. Cancer Res 1981; 4324–4330.Google Scholar
- 16.Abo T, Balch CM. A differentiation antigen of human NK and K cells identified by a monoclonal antibody (HNK-1). J Immunol 1981; 12: 1024–1029.Google Scholar